TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25548331

Group type: EXPERIMENTAL
Intervention: Vaccination reminder 'on'
Number of subjects: 8481

Group type: COMPARATOR
Intervention: Vaccination reminder 'off'
Number of subjects: 8481

Group type: EXPERIMENTAL
Intervention: Vaccination reminder 'on' in winter
Number of subjects: 8481

Group type: COMPARATOR
Intervention: Vaccination reminder 'off' in winter
Number of subjects: 8481

Group type: EXPERIMENTAL
Intervention: Vaccination reminder 'on' in fall
Number of subjects: 8481

Group type: COMPARATOR
Intervention: Vaccination reminder 'off' in fall
Number of subjects: 8481
Study: 23429258

Group type: EXPERIMENTAL
Intervention: Steroid withdrawal (SW)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Steroid withdrawal (SW) in prepubertal patients
Number of subjects: 30

Group type: COMPARATOR
Intervention: Steroid control (SC)
Number of subjects: 30
Study: 21827932

Group type: EXPERIMENTAL
Intervention: Sericite belt (experimental group)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo belt (control group)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Both groups (experimental and control)
Number of subjects: 104
Study: 18990373

Group type: EXPERIMENTAL
Intervention: P vaginal ring
Number of subjects: 20

Group type: COMPARATOR
Intervention: Vaginal gel
Number of subjects: 20
Study: 17264421

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Stretching
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control
Number of subjects: 72
Study: 14575730

Group type: EXPERIMENTAL
Intervention: 100 mg T enanthate
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 25
Study: 11833925

Group type: EXPERIMENTAL
Intervention: Incredible Years Parenting Program (8-12 weeks of weekly 2-hour parenting classes)
Number of subjects: 634

Group type: COMPARATOR
Intervention: Regular Head Start Program without parenting groups
Number of subjects: 634
Study: 9727892

Group type: EXPERIMENTAL
Intervention: T600/G12 (troglitazone 600 mg + glyburide 12 mg)
Number of subjects: 552
Study: 11271239

Group type: EXPERIMENTAL
Intervention: FK 506 therapy
Number of subjects: 545

Group type: COMPARATOR
Intervention: Cyclosporin A therapy
Number of subjects: 545
Study: 2736113

Group type: EXPERIMENTAL
Intervention: Instrumental anastomosis
Number of subjects: 113

Group type: COMPARATOR
Intervention: Manual anastomosis
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 113
Study: 4694404

Group type: EXPERIMENTAL
Intervention: Dietary treatment alone
Number of subjects: 200

Group type: COMPARATOR
Intervention: Oral hypoglycaemic drugs
Number of subjects: 200
Study: 30635177

Group type: EXPERIMENTAL
Intervention: REFOCUS‐PULSAR intervention
Number of subjects: 942

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 942
Study: 28330586

Group type: EXPERIMENTAL
Intervention: Structured Nintendo Wii protocol (n=8)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Conventional therapy (n=6)
Number of subjects: 14
Study: 26395298

Group type: EXPERIMENTAL
Intervention: Multidomain intervention to prevent disability in elders (MINDED)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 26060625

Group type: EXPERIMENTAL
Intervention: Levonorgestrel 0.75 mg given 12 hours apart
Number of subjects: 529

Group type: COMPARATOR
Intervention: Yuzpe regimen (ethinyl estradiol 100 μg plus 0.5 mg Levonorgestrel repeated after 12 hours)
Number of subjects: 529
Study: 21705296

Group type: EXPERIMENTAL
Intervention: Palpation by a sports medicine board‐certified staff physician
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Palpation by a sports medicine fellow
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Palpation by a physical medicine and rehabilitation resident
Number of subjects: 25
Study: 20055196

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Midazolam plus Fentanyl
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Midazolam plus Ketamine
Number of subjects: 259

Group type: COMPARATOR
Intervention: Drug-free group (Control)
Number of subjects: 259
Study: 16960118

Group type: EXPERIMENTAL
Intervention: Synthetic oligosaccharide-protein conjugate vaccine, administered as a single intramuscular injection.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control vaccine, details not specified.
Number of subjects: 0
Study: 15574080

Group type: EXPERIMENTAL
Intervention: 4 days of training abstinence
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 2 days of training abstinence
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 3 days of training abstinence
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 5 days of training abstinence
Number of subjects: 25
Study: 11560221

Group type: EXPERIMENTAL
Intervention: Propofol-N2O (P/N)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia using propofol (P/P)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Thiopental-N2O (T/N)
Number of subjects: 108
Study: 9586883

Group type: EXPERIMENTAL
Intervention: Regimen A: MTX 1,000 mg/m2 i.v. infused over 24 hours and MP 1,000 mg/m2 i.v. infused over 6 hours
Number of subjects: 1304

Group type: EXPERIMENTAL
Intervention: Regimen B: Low-dose repetitive MTX 30 mg/m2 orally every 6 hours for six doses and i.v. MP
Number of subjects: 1304

Group type: EXPERIMENTAL
Intervention: Regimen C: i.v. MTX alone
Number of subjects: 1304

Group type: EXPERIMENTAL
Intervention: CNS prophylaxis: age‐adjusted intrathecal MTX (ITM) changed to age‐adjusted triple intrathecal therapy (TIT)
Number of subjects: 1304
Study: 7821009

Group type: EXPERIMENTAL
Intervention: Taktosan Salbe (water-in-oil emulsion)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: RAWI Speerschutzcreme (oil-in-water emulsion)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (irritant only, no BC-pretreatment)
Number of subjects: 10
Study: 3280257

Group type: EXPERIMENTAL
Intervention: Cephalexin 500 mg po, qid for three extra days (Group A)
Number of subjects: 200

Group type: COMPARATOR
Intervention: No oral therapy (Group B)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Overall infection rate
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Median sternotomy infection rate
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Surgical wound infection rate
Number of subjects: 200
Study: 31543078

Group type: EXPERIMENTAL
Intervention: Psilocybin with psychological support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 30768859

Group type: EXPERIMENTAL
Intervention: Insulin administration 20 minutes before meal
Number of subjects: 30

Group type: COMPARATOR
Intervention: Insulin administration 0 minutes before meal
Number of subjects: 30
Study: 29032132

Group type: EXPERIMENTAL
Intervention: Baseline resting heart rate (HR)
Number of subjects: 1767

Group type: EXPERIMENTAL
Intervention: Change in HR from the preceding visit
Number of subjects: 1767

Group type: EXPERIMENTAL
Intervention: Time-updated resting HR at each visit
Number of subjects: 1767
Study: 26016586

Group type: EXPERIMENTAL
Intervention: Oral health education video game
Number of subjects: 110

Group type: COMPARATOR
Intervention: Verbal oral health education
Number of subjects: 110
Study: 25239835

Group type: EXPERIMENTAL
Intervention: ATL1102 (200 mg subcutaneously injected 3 times in the first week and twice weekly for 7 weeks)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: ATL1102
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 22826621

Group type: EXPERIMENTAL
Intervention: CO2 insufflation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 60
Study: 19238693

Group type: EXPERIMENTAL
Intervention: Adjuvant trastuzumab (Herceptin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 17711151

Group type: EXPERIMENTAL
Intervention: Regular exercise programme
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 160
Study: 15240438

Group type: EXPERIMENTAL
Intervention: Joint crisis plan intervention
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 160
Study: 11152433

Group type: EXPERIMENTAL
Intervention: Amoxycillin 1 g bd
Number of subjects: 395

Group type: COMPARATOR
Intervention: Amoxycillin 500 mg tds
Number of subjects: 395
Study: 9014544

Group type: EXPERIMENTAL
Intervention: Target-controlled infusion of propofol (4 micrograms.ml‐1 target blood concentration, increased by 2 micrograms.ml‐1 after 3 min of consciousness not lost)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Manual infusion of propofol at 1200 ml.h‐1
Number of subjects: 90

Group type: COMPARATOR
Intervention: Manual infusion of propofol at 600 ml.h‐1
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Target-controlled infusion of propofol
Number of subjects: 90

Group type: COMPARATOR
Intervention: Manual infusion of propofol (both rates)
Number of subjects: 90
Study: 7884236

Group type: EXPERIMENTAL
Intervention: Intraoperative pelvic hyperthermochemotherapy (IOPHC) with 40 micrograms/ml mitomycin C at 45 degrees C for 90 min
Number of subjects: 62

Group type: COMPARATOR
Intervention: Surgery alone (control group)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Both groups (IOPHC and control)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: IOPHC treatment
Number of subjects: 62
Study: 2448428

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy with high-dose methotrexate (HDMTX) and the triple drug combination of bleomycin, cyclophosphamide, and dactinomycin (BCD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy with doxorubicin (DOX) and cisplatin (CPDD) for poor responders
Number of subjects: 0

Group type: COMPARATOR
Intervention: Preoperative chemotherapy with DOX/CPDD
Number of subjects: 0

Group type: COMPARATOR
Intervention: Postoperative salvage chemotherapy with BCD and CPDD/ifosfamide (IFO)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Good responders receiving postoperative chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Good responders receiving postoperative chemotherapy in control arm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall study arm
Number of subjects: 0

Group type: COMPARATOR
Intervention: Overall control arm
Number of subjects: 0
Study: 29453445

Group type: EXPERIMENTAL
Intervention: Ketamine (NMDAR antagonist)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 27022958

Group type: EXPERIMENTAL
Intervention: Telephone counseling (reviewing symptom management and return to activity with parents at 1 week and 1 month postinjury)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Usual care (no formalized follow‐up)
Number of subjects: 66
Study: 25023947

Group type: EXPERIMENTAL
Intervention: IntelliCap® device with diltiazem (60 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Mylan formulation (SR diffusion coated beads)
Number of subjects: 14
Study: 22615342

Group type: EXPERIMENTAL
Intervention: Atorvastatin (40 mg/d)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Mediterranean diet with low cholesterol intake (<300 mg/d)
Number of subjects: 30
Study: 20231684

Group type: EXPERIMENTAL
Intervention: HSPB1 promoter -1271C allele
Number of subjects: 1152

Group type: COMPARATOR
Intervention: HSPB1 promoter -1271G allele
Number of subjects: 1152
Study: 18227981

Group type: EXPERIMENTAL
Intervention: Epidural analgesia with 0.125% bupivacaine plus 50 microg fentanyl
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intravenous analgesia with 1.5 microg/ml/kg/h fentanyl followed by 1.0 microg/ml/kg/h fentanyl
Number of subjects: 30
Study: 15959668

Group type: EXPERIMENTAL
Intervention: IVIg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 12623333

Group type: EXPERIMENTAL
Intervention: Color-flow duplex scanning
Number of subjects: 32
Study: 10551568

Group type: EXPERIMENTAL
Intervention: 1.8 g/kg perflubron emulsion with colloid (total = 450 ml) at FIO2 = 1.0
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: 0.9 g/kg perflubron emulsion with colloid (total = 450 ml) at FIO2 = 1.0
Number of subjects: 147

Group type: COMPARATOR
Intervention: Autologous blood harvested during acute normovolemic hemodilution at FIO2 = 0.40
Number of subjects: 147

Group type: COMPARATOR
Intervention: Colloid at FIO2 = 1.0
Number of subjects: 147
Study: 8903371

Group type: EXPERIMENTAL
Intervention: 3 MU of interferon alfa‐2b thrice weekly for 12 weeks
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: 5 MU of interferon alfa‐2b thrice weekly for 12 weeks
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: 10 MU of interferon alfa‐2b thrice weekly for 12 weeks
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Continued therapy at 3 MU for an additional 12 weeks for nonresponders
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Escalated dose from 3 or 5 MU to 10 MU for nonresponders
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Higher doses of interferon (above 3 MU)
Number of subjects: 248
Study: 1437036

Group type: EXPERIMENTAL
Intervention: Chlorhexidine rinse
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Nystatin rinse
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Saline solution rinse
Number of subjects: 86
Study: 3849034

Group type: EXPERIMENTAL
Intervention: Behavioral-coping technique
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Cognitive-coping technique
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Concrete sensory information
Number of subjects: 168

Group type: COMPARATOR
Intervention: Control information about the posthospital experience
Number of subjects: 168
Study: 30413902

Group type: EXPERIMENTAL
Intervention: High-PNI group
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Low-PNI group
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Nomogram
Number of subjects: 228
Study: 30204493

Group type: EXPERIMENTAL
Intervention: Interval training in hypoxia (IHT; FIO2 = 17.2%; n=13)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Repeated-sprint training in hypoxia (RSH; FIO2 = 17.2%; n=15)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Interval training in normoxia (INT; n=15)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Repeated-sprint training in normoxia (RSN; n=18)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Interval training in hypoxia (IHT; FIO2 = 17.2%) and Repeated-sprint training in hypoxia (RSH; FIO2 = 17.2%)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Interval training in hypoxia (IHT) and Repeated-sprint training in hypoxia (RSH)
Number of subjects: 86
Study: 25236992

Group type: EXPERIMENTAL
Intervention: Roland Morris Questionnaire (RMQ)
Number of subjects: 701

Group type: EXPERIMENTAL
Intervention: RMQ to EQ-5D mapping model
Number of subjects: 701

Group type: EXPERIMENTAL
Intervention: RMQ to SF-6D mapping model
Number of subjects: 701
Study: 21850408

Group type: EXPERIMENTAL
Intervention: Antirefluxive DJ stent
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional DJ stent
Number of subjects: 29
Study: 21199471

Group type: EXPERIMENTAL
Intervention: Ankylosing Spondylitis Quality of Life Questionnaire (ASQoL)
Number of subjects: 63
Study: 18087084

Group type: EXPERIMENTAL
Intervention: 2 g single oral dose azithromycin
Number of subjects: 75

Group type: COMPARATOR
Intervention: 250 mg parenteral ceftriaxone
Number of subjects: 75
Study: 16253590

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stent
Number of subjects: 1314

Group type: COMPARATOR
Intervention: Bare-metal stent (Control)
Number of subjects: 1314
Study: 12010164

Group type: EXPERIMENTAL
Intervention: Implant prostheses (IG, n = 26)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Conventional dentures (CDG2, n = 35)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Conventional dentures (CDG1, n = 22)
Number of subjects: 83
Study: 10096530

Group type: EXPERIMENTAL
Intervention: enlimomab
Number of subjects: 262

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 262
Study: 7655889

Group type: EXPERIMENTAL
Intervention: Non-cued movements in Parkinson's disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Externally cued movements in Parkinson's disease
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-cued movements in controls
Number of subjects: 0

Group type: COMPARATOR
Intervention: Externally cued, predictable movements in controls
Number of subjects: 0

Group type: COMPARATOR
Intervention: Externally cued, unpredictable movements in controls
Number of subjects: 0
Study: 2681593

Group type: EXPERIMENTAL
Intervention: Calcium antagonists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other drugs modifying myogenic tone
Number of subjects: 0
Study: 1093507

Group type: EXPERIMENTAL
Intervention: Marihuana
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29389691

Group type: EXPERIMENTAL
Intervention: IPC-2h (Ischemic Preconditioning 2 hours before swimming)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: IPC-24h (Ischemic Preconditioning 24 hours before swimming)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Con (Control with sham intervention 2 hours before swimming)
Number of subjects: 20
Study: 29950106

Group type: EXPERIMENTAL
Intervention: Condom use self-efficacy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Condom use norms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attitudes toward condom use
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Condom use intentions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mediation analysis of condom use intentions
Number of subjects: 0
Study: 28333611

Group type: EXPERIMENTAL
Intervention: Transcendental Meditation (TM)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 22
Study: 25776217

Group type: EXPERIMENTAL
Intervention: Stress condition (experimental)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control condition (non-stress)
Number of subjects: 120
Study: 23759361

Group type: EXPERIMENTAL
Intervention: Caregiver educational programme performed by nurses to improve skills in meal support, nursing care, welfare care, or symptom management.
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Caregiver educational programme (experimental group)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned in the abstract)
Number of subjects: 67
Study: 21800090

Group type: EXPERIMENTAL
Intervention: Traditional risk factor scoring
Number of subjects: 865

Group type: EXPERIMENTAL
Intervention: Assessment for both risk factors and subclinical atherosclerosis
Number of subjects: 865

Group type: COMPARATOR
Intervention: Survey-only group
Number of subjects: 865
Study: 18321517

Group type: EXPERIMENTAL
Intervention: Naproxen suppository
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo suppository
Number of subjects: 142
Study: 17060041

Group type: EXPERIMENTAL
Intervention: U-Clip for proximal anastomoses
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: U-Clip for distal anastomoses
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: U-Clip for distal anastomoses in interim angiography
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: U-Clip for proximal anastomoses in interim angiography
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Overall hospital mortality
Number of subjects: 118
Study: 12661806

Group type: COMPARATOR
Intervention: Salbutamol (100 microg/puff) alone
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Beclomethasone diproprionate (50 microg/puff) with Salbutamol (100 microg/puff) by metered dose inhaler with or without spacer
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Beclomethasone diproprionate (50 microg/puff) with Salbutamol (100 microg/puff) without spacer
Number of subjects: 57
Study: 11132785

Group type: EXPERIMENTAL
Intervention: 6 to 20 channels of stimulation for normal-hearing children and adults
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nucleus 22 cochlear implant
Number of subjects: 0
Study: 9366582

Group type: EXPERIMENTAL
Intervention: R‐568 20 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: R‐568 80 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: R‐568 160 mg
Number of subjects: 20
Study: 8447215

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 0.1 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 0.3 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 0.5 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (0 mg intrathecal morphine)
Number of subjects: 80
Study: 2439780

Group type: EXPERIMENTAL
Intervention: Bisoprolol 5 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Bisoprolol 10 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Bisoprolol 20 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Long-term treatment with bisoprolol (dose adjustments up or down)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Adverse effects of bisoprolol
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Laboratory safety tests
Number of subjects: 48
Study: 29458923

Group type: EXPERIMENTAL
Intervention: Aquatic Ai Chi program
Number of subjects: 29

Group type: COMPARATOR
Intervention: Dry land conventional Western physical therapy intervention
Number of subjects: 29
Study: 27431654

Group type: EXPERIMENTAL
Intervention: Adolescent Coping with Depression Course (ACDC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 24855350

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/vilanterol
Number of subjects: 3255

Group type: COMPARATOR
Intervention: Vilanterol alone
Number of subjects: 3255
Study: 23090339

Group type: EXPERIMENTAL
Intervention: Nasal continuous positive airway pressure (NCPAP) via nasal prongs
Number of subjects: 120

Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure (NCPAP) via nasal mask
Number of subjects: 120
Study: 20132902

Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS over S1
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 27